NAN, D.; ABRAIRA-MERIEL, C.; DE LA ROZ-FERNANDEZ, S.; MAESTRE-OROZCO, T.; HERNANDEZ, J. L.; FERNANDEZ-AYALA, M. Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients with Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report. European Journal of Case Reports in Internal Medicine, [S. l.], v. 8, n. 10, 2021. DOI: 10.12890/2021_002821. Disponível em: https://www.ejcrim.com/index.php/EJCRIM/article/view/2821. Acesso em: 29 apr. 2024.